Related Experiment Videos
Richter syndrome: an aggressive transformation
1CancerCare Manitoba, Winnipeg, Canada.
Oncology Nursing Forum
|March 26, 2015
Summary
This case study details a 71-year-old male with chronic lymphocytic leukemia (CLL). Standard first-line chemotherapy (FCR) effectively treated his symptoms with minimal side effects.
Area of Science:
- Hematology
- Oncology
Background:
- Chronic lymphocytic leukemia (CLL) is a common hematologic malignancy.
- Patients often present with lymphadenopathy and splenomegaly causing discomfort.
Observation:
- A 71-year-old male diagnosed with CLL presented with generalized lymphadenopathy and splenomegaly.
- The patient experienced significant abdominal discomfort due to his condition.
Findings:
- Treatment with six cycles of fludarabine, cyclophosphamide, and rituximab (FCR) was initiated.
- The patient tolerated FCR chemotherapy well, reporting only mild nausea.
- Significant resolution of lymphadenopathy and splenomegaly was observed post-treatment.
Implications:
- FCR chemotherapy is an effective first-line treatment for CLL.
- This regimen demonstrates a favorable safety profile in elderly patients.
- Successful management of CLL symptoms can significantly improve patient quality of life.